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Abstract
The excretion of bilirubin and therefore the relief of jaundice is dependent upon at least three
factors. First, the bilirubin must be conjugated and thus converted into a water soluble compound:
this means its conversion to an ester glucuronide although other conjugates may also be formed.
Secondly, there is the problem of the transport of bilirubin through the hepatic cell. A defect in
either the up-take of bilirubin or the secretion of conjugated bilirubin may result in jaundice such
as is seen in the various types of familial hyperbilirubinemia. Thirdly, there is the possibility of
alternative catabolic pathways for bilirubin: this approach to the problem has, however, not yet
received the attention of investigators.
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It gives me very great pleasure to be here in Okayama. I have long known
of the very excellent work that has been done il} this University in connection
with bile pigments so that it has been a wonderful experience for me to have
the opportunity of talking with Professor Kosaka, Dr. Sakamoto and others of
this department.
Today I am going to talk about some of the defects in bilirubin metabolism
which may cause jaundice. It has been known for over forty years that for bili-
rubin to be excreted in the bile and urine, it must first be converted from a
lipid-soluble pigment into one which is water-soluble. This raises the question as
to what is the nature of this water-soluble pigment. It is due to Professor
Kosaka and Professor Yamaoka1 that the first real clue to this problem was
obtained. They were able to show that the excretion of bilirubin involves its
conversion into an ester. It was at this stage that Dr. Lathe, Mrs. Cole and
myself at Queen Charlotte's Maternity Hospital in England started to investigate
the problem.
We have employed the technique of reverse phase chromatography using
silicone treated kieselgur and with a chloroform, carbon tetrachloride, methanol
solvent system at pH 6.0 were able to separate the bile pigments into two com-
ponents, namely bilirubin and a second component which gives the direct van
den Bergh reaction, in the absence of protein and bile acids2• If the solvent
system is changed to butanol and water the direct reacting pigment can be re-
solved into two components namely, pigment I and pigment II (Fig. 1)~. Pigment
II is the main pigment in bile, while both pigments I and II can be found in
serum and in urine. We then tried to isolate and identify these pigments but
they are extremely unstable, and so we had to tackle the problem in a different
way. Kawai-l in this hospital and myself had independently observed that if you
examine the products of the van den Bergh reaction on icteric serum that bili-
rubin gives you one azo pigment (azo pigment A) whereas pigment II gives
you a different one (azo pigment B). Using reverse phase chromatography,
* The paper read at Okayama University Medical School, Okayama, Japan, Sept. 14,
1960.
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Fig. 1. Behaviour of bile pigments and their diazo products on reverse
phase partition chromatograms (Nosslin, B.: Scand. J. Clin. Lab. Invest.
12, Suppl. 49, 1960).
paper chromatography, or counter-current distribution techniques it is possible
to separate azo pigments A and B, both of which are relatively stable. We were
able to isolate azo' pigment B5, as did Dr. Schmid6 in the United States, and
found that azo pigment B is the ester glucuronide of azo pigment A (Table 1).
Table 1. Identification of Pigment n.
IDENTIFICATION OF PIGMNT ]I
alkali
----- Pigment A + glucuronic acid
,a-glucuronidase
2. I mol Bilirubin
----- 2 mols Pigment A
THEREFORE
I mol Pigment ]I
----- 2 mols Pigment B
Conclusion: Pigment]I =ester diglucuronide of bilirubin
Evidence for this statement is based on the observation that when azo pigment
B is treated with mild alkali or with the enzyme ;9-glucuronidase, pigment A and
glucuronic acid are formed. Now, Overbeek and his collaborators7 had shown
that one molecule of bilirubin will give two molecules of azo pigment A. We,
therefore, presumed that one molecule of pigment II would give two molecules
of azo pigment B and concluded that pigment II is the ester diglucuronide of
bilirubin (Fig. 2), the glucuronyl radicals being attached through the proprionic
groupings of the bilirubin molecule. Pigment I forms both azo pigment A and
2
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Fig. 2. Structure of bile pigments (Billing, B. H.: Advances in
Clinical Chem. 2, 267, 1960).
187
azo pigment B in the van den Bergh reaction and appears to be bilirubin mono-
glucuronide.
Although the main means of excreting bilirubin involves conjugation as the
glucuronide, other detoxifying mechanisms may be employed and must be con-
sidered. Mild alkali treatment of icteric serum (or bile) will convert most, but
not all, of the conjugated ("direct") bilirubiI?- into bilirubin; the remaining con-
jugated bilirubin has been shown to have a non-glucuronide structure. The
possibility that this might be bilirubin sulphate was examined by Isselbacher and
McCarthy8 in America (Fig. 3). They injected radioactive 536 into a rat and
Auto·
rodioqraphy
ollerS"-
Treatment with Treatment willl
lucuronidose alkali.
A
--......---l8
Fig. 3. The chromatographic behaviour
of purified azo pigments obtained from rat
bile after the injection of radioactive sulphate,
and after treatment with ,B-glucuronidase
and alkali (0. IN NaOH). The correspond-
ing autoradiograph shown on the left indi-
cates that the radioactivity directly coincides
with the azo-pigment B (drawn from data
given by Issselbacher and McCarthy, 1959).
(J. Clin. Invest. 38, 645, 1959)
collected the bile. After diazotisation the resulting azo pigment B was isolated
by chromatography and autoradiograms showed that it contained 5 36• In addi-
tion, Dr. Kondo in this department has demonstrated that some of the bile
pigments may be excreted as ester phosphates and there is some evidence that
glycine conjugation may also occur.
An examination of the distribution of the 3 bile pigments in different types
of jaundice shows that bilirubin is the main pigment in hemolytic disease, both
in the adult and in the new born, and also in the premature infant (Fig. 4).
3
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Fig. 4. Examples of the relative amounts of bilirubin pigment I and
pigment II found in plasma in various conditions and in fistula bile.
<Billing, B. H. + Lathe, G. H. Amer. J. med: 24, 111, 1958).
In bile, as previously mentioned, there are two pigments, pigment H and some
pigment I, so that if there is an obstruction to the flow of bile, one would expect
that these two pigments would accumulate in the blood. Thus in obstructive
jaundice, the pigment that accumulates most is pigment H, and there is also
some pigment I and bilirubin. On the other hand, in hepatitis, or hepato-cellular
disease there is more pigment I than pigment H. In other words, I think, there
is probably a defect in the conversion of the monoglucuronide to the diglucuro-
nide. The different pictures seen in these two types of jaundice suggested that
a comparison of the relative amounts of pigment I and pigment H might prove
to be a useful diagnostic test for the differentiation of obstructive jaundice and
hepatocellular disease.
Dr. Bollman and his colleagues at the Mayo Clinic9 examined over 100 sera
and found that in hepato-cellular disease less than 50 per cent of the conjugated
pigment is pigment II i. e. pigment I is the dominant pigment (Fig. 5). In
biliary obstruction, however, there is more than 50 per cent of the conjugated
pigment as pigment n. Unfortunately there is some overlap in the results and
the chromatographic technique is not sufficiently accurate to make this a good
test.
Bilirubin glucuronide is formed by the action of a specific enzyme, a glu-
curonyl transferase with uridine diphosphate glucuronic acid as the glucuronyl
donor (Fig. 6)1.0,11 The glucuronyl transferase is found mainly in the liver micro-
somes and to a small extent in the kidney and intestinal tissue. At present,
however, there is no evidence that tissues other than the liver are taking part
in the synthesis of bilirubin glucuronide in vivo..
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Fig. 5. Distribution of direct-reacting
pigment II in the serum of patients suffer-
ing from liver disease. (Billing, B. H. :
Advances in Clin. Chem. 2, 267, 1960)
Fig. 6. A possible mechanism for the con-
jugation of bilirubin with glucuronic acid.
(Billing, B. H and Lathe, G. H. Amer. J, med,
24, 111. 1958)
A deficiency of glucuronyl transferase would be expected to cause an
accumulation of bilirubin in the body and such is the position in the new born
baby. It can be shown in animal experiments and also from the analysis of liver
tissue obtained from new born babies that there is a relative or absolute de-
ficiency of glucuronyl transferase at birth.
Examination of the changes in plasma bile pigment concentration during
the neonatal period shows that the highest levels of bile pigment concentration
are attained in the smallest babies (Fig. 7). Also, the smaller the baby the
longer it takes to reach the maximum level. Thus, with a six pound baby the
highest bile pigment concentration may be seen in four days, whereas with a
three pound baby it may take seven days. This is due to the fact that the very
small baby has a less mature liver and therefore there is less glucuronyl trans-
ferase. As soon as sufficient glucuronyl transferase has developed then the baby
will recover, since the bilirubin can then be excreted as bilirubin glucuronide
and removed in the bile in the normal way.
5
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Fig. 7. The course of plasma bile pigment
concentration during the neonatal period of five
typical babies of varying birth weights (Billing
et al. Brit. Med. J. ii, 1263-1265, 1954).
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In hemolytic disease in the new born, the trouble is two fold. First of all,
the infant is receiving an increased load of bilirubin due to the hemolytic process
and then secondly, there is this problem of hepatic immaturity. The concentra-
tion of bilirubin in the plasma will
therefore rise very quickly and attain
a very much higher level. Unless
exchange transfusion therapy is in-
stituted quickly the plasma bilirubin
may reach dangerous levels so that
the bilirubin may go into the brain
causing kernicterus.
The toxicity of bilirubin has
been shown by in vitro experiments,
in that it will uncouple oxidative
phosphorylation. It will also de-
crease the oxygen consumption
of brain brei, a process which
can be reversed by adding cyto-
chrome C, methylene-blue or DPN
to the mixture. Exactly how the
bilirubin acts, in vivo is uncertain
but it is obvious that it will upset the
metabolism of the brain tissue. Very
high doses of bilirubin given to
animals will also cause neurological
damage.
Conjugated bilirubin on the other hand does not appear to be toxic so that
in adults brain damage is not associated with severe hyperbilirubinemia since
the high levels of pigment are due mainly to conjugated bilirubin and not in-
direct bilirubin. It is very rare that brain damage results in infants unless the
bilirubin concentration in the serum goes above 20 mg%. But there are occasions
when it has been reported that brain jaundice results from very much lower
levels. Several years ago, in the United States in a premature nursery13, the
babies were given two different types of antibiotic treatment, one group received
oxytetracycline and the other group received gantrisin (a sulfa drug). 44 of the
95 babies who received the gantrisin treatment died. In the other group, of
similar size, receiving oxytetracycline therapy only 22 died. The difference in
the number of deaths was due to a very high incidence of kernicterus. The in-
creased brain damage occurred in spite of the fact that the mean level of serum
6
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bilirubin attained was only 8.0 mg % which was considerably less than that in
the oxytetracycline group, which had only one case of kernicterus and a max-
imum mean serum bilirubin level of 16.4 mg %. In vitro experiments have sug-
gested that the gantrisin acts by displacing the bilirubin from serum and tissue
albumin and that the 'free' bilirubin is then able to get into the brain. Other
drugs such as asprin also act in this way and may make the newborn infant
more susceptable to kernicterusl "
We have seen that jaundice in the new born is often due to a deficiency
of glucuronyl transferase and one may perhaps wonder whether this enzyme
deficiency occurs in other species than the human. This has been shown to be
the case in a homozygous strain of Wistar rats, known as Gunn rats, which
have serum unconjugated bilirubin levels of about 5 mg/100 ml (Table 2). This
Table 2. Glucuronide Excretion in Jaundiced and Normal Rats
DOSE MODE OF URINARY EXCRETIONWISTAR COMPOUND OF GLUCURONIC ACID
RATS GIVEN GIVEN ADMINISTRA- (% of dose administration)per 100gm TION MEAN OR RANGE
Jaundiced o-aminobenzoic
mg. I
acid 25 Oral 22.8
Non-jaundiced o-aminobenzoic 25 Oral 70.11itter mates acid
Normal Controls o-aminobenzoic 25 Oral 93.2
acid
Jaundiced Soduim 100 Intraperitoneal 8.4-10.9o-aminobenzoate
Non-jaundiced Sodium 100 Intraperitoneal 25.4litter mates o-aminobenzoate
Jaundiced Menthol 25 Oral 28-42
Non-jaundiced Menthol 25 Oral 70-72litter mates
R. Schmid et al. :.T. Clin. Invest. 37, 1123, 1958
hyperbilirubinemia occurs in spite of a normal liver histology. If an ordinary
rat is given an oral dose of aminobenzoic acid then 93 % of the administered
aminobenzoic acid will be excreted as glucuronide in the urine. The same dose
of aminobenzoic acid to one of these jaundiced rats, however, will result in
\
only 23.8 % being excreted as glucuronide, thus indicating· the difficulty they
have in excreting substances as glucuronides. It can be shown that there
is a very definite lack of glucuronyl transferase in the liver of the animal
7
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Fig. 8. Bilirubin excretion (Schmid et al. :
J. Clin. Invest. 37, 1123, 1958).
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and this is probably the reason that
they remain jaundiced.
An elegant experiment by Dr.
Schmid and his colleagues has shown
that the excretory mechanism for con-
jugated bile pigments is normal (Fig.
8) in Gunn rats. He canulated the bile
duct of one of these rats and then in-
jected bilirubin, collected the bile and
measured the concentration of biliru-
bin; little change was observed after
the injection but if he gave bilirubin
glucuronide instead of bilirubin then
the increase in pigment concentration
in the bile was very notable and equi-
valent to that observed in a normal
rat given a similar does of bilirubin.
In other words, the ability of the Gunn rat to excrete bilirubin glucuronide is
normal. So that here is an example of jaundice in an animal which is due to
an enzyme deficiency.
The possibility that a similar enzyme deficiency occurs in adults has been
examined by studying four types of familial hxperbilirubinemia (Table 3). In
the first group, originally described by Crigler and Najjar15 , the patients have
serum bilirubin levels of the indirect type of about 20 mg/ 100 ml. and are often
mentally defective, with brain damage associated with jaundice since birth.
Some members of these families are, however, intensely jaundiced but otherwise
normal. In these patients there is no doubt that the defect is an enzymic one,
but in the less severe Gilbert's disease, in which the bilirubin level is probably
not much more than 3 or 4 mg/ 100 ml, it is not possible to demonstrate so
clearly that there is an enzyme defect. A more likely explanation for the jaun-
dice seems to be a defect in the mechanism whereby bilirubin is transferred
from the serum albumin into the liver cells. Exactly what the defect is I do not
know, and this is only just a working hypothesis.
There are also two rather rare types of familial hyperbilirubinemia in which
conjugated bilirubin, as well as bilirubin accumulates in the serum in spite of
the absence of any evidence for an obstructive type of jaundice. The liver biopsy
will be normal in the group of patients first described by Dubin and 10hnson16
except for a very curious black pigment in the centrilobular regions of the liver.
This pigment is a very useful diagnostic aid but is not responsible for the ac-
8
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Table 3. Familial Hyperbilirubinemia
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FAMILIAL HYPERBILIRUBINAEMIA
I
CRIGLER-
I GILBERTS I
DUBIN
I ROTORNAJJAR JOHNSON
Liver Histology Normal Normal Pigmentation Normal
Plasma
Bilirubin +++ + + +
Conjugated
Bilirubin - - ++ ++
.
Defects
--
Enzyme +++ ? - -
Bilirubin
Uptake + + ? ?
Conjugated
Bilirubin - - ++ ++
Secretion
Bromsulphalein
- - ++ ++Retention
cumulation of conjugated pigment in the serum. In the other group, first described
by Dr. Rotor and his group in the Philippines17, the liver appears to be normal
in structure when examined by normal light and electron microscopy so that
same other reason must be found to explain why these people are jaundiced.
We tried to investigate this matter by giving the patients an intravenous dose
of bilirubin (2mg/kg). Such an administration in the normal results in an increase
in the amount of indirect bilirubin in the serum and a very small increase in
the amount of conjugated bilirubin; in four hours these levels have returned to
normal but in the patient with the Rotor syndrome the picture is quite diffe-
rent, for the indirect bilirubin concentration goes up and stays up and in four
hours still has not returned to normal. The same thing happens with the con-
jugated bilirubin thus indicating a defect in the excretion of conjugated bilirubin.
This defect becomes more apparent in the case of the Dubin-Johnson syndrome
illustrated in (Fig. 9). After the injection the total bile pigments in the serum
rose quickly and then only very slowly decreased. The reason for this is not
that the up-take of indirect bilirubin has almost completely stopped but that there
is an increase in the conjugated bilirubin due to its reappearance in the circula-
tion instead of the bile. It seems likely that this defect in excretion occurs at the
9
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Fig. 9. Effect of intravenous bilirubin (2 mg/Kg) on the serum bile
pigment concentration in a normal subject and patients with the Rotor
Syndrome and Dubin-Johnson Syndrome.
cell membrane but at present nothing is known of its nature. There is certainly
no doubt that the formation of glucuronide in these patients is perfectly normal.
This inability to excrete conjugated bilirubin is found on rare occasions in the
new born following exchange transfusions for erythroblastosis. 48 hours after
birth when sufficient glucuronyl transferase has developed it may be noted that
the indirect bilirubin level drops while the conjugated level rises so that the
figure for total bile pigment concentration remains relatively unchanged (Fig. 10).
10
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Fig. 10. Conjugated hyperbilirubinemia following exchange
transfusions for erythroblastosis.
Dr. Jouvenceaux18 in France has reported several families who have thi~ tempo-
rary problem of excreting conjugated bilirubin. In a week or so the jaundice
disappears. Biopsies have not been performed but there is no clinical evidence
to suggest that any gross abnormality in the liver exists.
No mention so far has been made of renal excretion of bilirubin mainly
because not much is known about it. From the literature it would appear that
bilirubin is excreted to a very small extent by the kidney and is a tubular pro-
cess. It would have seemed reasonable to postulate that when one recovers from
jaundice that the disappearance of bile pigments could be accounted for by an
increased excretion of pigment in the urine or in the faeces. However, as shown
in (Fig. 11) the urine bilirubin excretion parallels the fall in the serum level and
although there is an increase in the fecal urobilinogen this is considerably de-
layed and could not possibly explain the disappearance of the bile pigments. So
we have the problem of what happens to the bile pigments when they disappear
upon release of an obstruction or recovery from hepatitis. At present, I am
afraid we do not know the answer and this will obviously be another field for
considerable research. Perhaps the pigment breaks down into dipyrrols, which
are colourless and do not give a positive van den Bergh reaction. We are at
present in our laboratory making some radioactive bilirubin in the hopes that
this will give us some help with the problem.
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Fig. 11. Changes in serum bilirubin, urine bilirubin and faecal uronilinogen
in a patient with hepatitis treated with prednisone (50 mg. /day).
SUMMARY
The excretion of bilirubin and therefore the relief of jaundice is dependent
upon at least three factors. First, the bilirubin must be conjugated and thus
converted into a water soluble compound: this means its conversion to an ester
glucuronide although other conjugates may also be formed. Secondly, there is
the problem of the transport of bilirubin through the hepatic cell. A defect
in either the up-take of bilirubin or the secretion of conjugated bilirubin may
result in jaundice such as is seen in the various types of familial hyperbiliru-
binemia. Thirdly, there is the possibility of alternative catabolic pathways for
bilirubin: this approach to the problem has, however, not yet received the
attention of investigators.
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